Faivre Magalie, Renoux Céline, Bessaa Amel, Da Costa Lydie, Joly Philippe, Gauthier Alexandra, Connes Philippe
Université de Lyon, Institut des Nanotechnologies de Lyon INL-UMR 5270 CNRS, Université Lyon 1, Villeurbanne, France.
Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie Vasculaire et du Globule Rouge", UCBL1, Villeurbanne, France.
Front Physiol. 2020 Jun 12;11:576. doi: 10.3389/fphys.2020.00576. eCollection 2020.
Despite the fact that Red Blood Cells (RBCs) have been intensively studied in the past 50 years to characterize mechanical phenotypes associated with both healthy and pathological states, only ektacytometry (i.e., laser diffractometry) is currently used by hematologists to screen for RBC membrane disorders. Therefore, the development of new diagnostic tools able to perform analysis at the scale of a single cell, over a statistically relevant population, would provide important complementary information. But these new diagnostic tools would have to be able to discriminate between different disorders causing a change in RBCs mechanical properties. We evaluated the mechanical response of artificially rigidified RBCs flowing through a microfluidic constriction. The geometry consists in a 50 μm wide channel with a succession of 14 tooth-like patterns, each composed of a 5 μm wide and 10 μm long constriction, associated with a 25 μm wide and 10 μm long enlargement. RBCs deformability was altered using two chemical treatments, known to affect RBCs membrane surface area and membrane deformability, lysolecithine (LPC) and diamide, respectively. Differences between samples were highlighted by the representation of the inverse of the shape recovery time (1/ ), versus the extension at the exit of the constriction, . The results demonstrate that our approach is able to provide a direct signature of RBCs membrane composition and architecture, as it allows discriminating the effect of changes in RBCs membrane surface area from changes in RBCs membrane deformability. Finally, in order to evaluate the potential of our microsystem to detect pathological cells, we have performed preliminary experiments on patients with Hereditary Spherocytosis (HS) or Sickle Cell Anemia (SCA).
尽管在过去50年里,人们对红细胞(RBCs)进行了深入研究,以表征与健康和病理状态相关的机械表型,但目前血液学家仅使用血细胞变形性测定法(即激光衍射法)来筛查红细胞膜疾病。因此,开发能够在单个细胞水平上对具有统计学意义的群体进行分析的新诊断工具,将提供重要的补充信息。但这些新诊断工具必须能够区分导致红细胞力学特性改变的不同疾病。我们评估了流经微流体收缩通道的人工硬化红细胞的力学响应。该通道的几何形状为一个50μm宽的通道,带有一系列14个齿状图案,每个图案由一个5μm宽、10μm长的收缩部分和一个25μm宽、10μm长的扩张部分组成。分别使用两种已知会影响红细胞膜表面积和膜变形性的化学处理方法,即溶血卵磷脂(LPC)和二酰胺,来改变红细胞的变形性。通过绘制形状恢复时间的倒数(1/ )与收缩通道出口处的伸长量( )的关系图,突出了样品之间的差异。结果表明,我们的方法能够提供红细胞膜组成和结构的直接特征,因为它能够区分红细胞膜表面积变化的影响和红细胞膜变形性变化的影响。最后,为了评估我们的微系统检测病理细胞的潜力,我们对遗传性球形红细胞增多症(HS)或镰状细胞贫血(SCA)患者进行了初步实验。